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Abstract
Multiple genes involved in endocytosis and endosomal protein trafficking in Drosophila have been shown to function as
neoplastic tumor suppressor genes (nTSGs), including Endosomal Sorting Complex Required for Transport-II (ESCRT-II)
components vacuolar protein sorting 22 (vps22), vps25, and vps36. However, most studies of endocytic nTSGs have been
done in mosaic tissues containing both mutant and non-mutant populations of cells, and interactions among mutant and
non-mutant cells greatly influence the final phenotype. Thus, the true autonomous phenotype of tissues mutant for
endocytic nTSGs remains unclear. Here, we show that tissues predominantly mutant for ESCRT-II components display
characteristics of neoplastic transformation and then undergo apoptosis. These neoplastic tissues show upregulation of c-
Jun N-terminal Kinase (JNK), Notch, and Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT)
signaling. Significantly, while inhibition of JNK signaling in mutant tissues partially inhibits proliferation, inhibition of JAK/
STAT signaling rescues other aspects of the neoplastic phenotype. This is the first rigorous study of tissues predominantly
mutant for endocytic nTSGs and provides clear evidence for cooperation among de-regulated signaling pathways leading
to tumorigenesis.
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Introduction
Tumor development involves destabilization of the well-
controlled processes of cell proliferation, cell polarization, and
programmed cell death that are tightly regulated by widely
conserved signaling pathways. Therefore, genes that act as
regulators of these signaling pathways may behave as nTSGs. In
Drosophila, as well as in other organisms, genes that control
endocytosis and endosomal protein sorting behave as nTSGs.
Such endocytic nTSGs include avalanche (avl) [1], Rab5 [1], vps45
[2], Rabenosyn (Rbsn) [2], tumor suppressor protein 101 (tsg101 aka
erupted (ept) or vps23) [3], vps28 [4], vps25 [5–7], vps22 (aka larsen
(lsn)) [8], vps20 [4], shrub (shrb) [4], vps2 [4], and vps4 [9]. These
endocytic nTSGs are involved in endocytosis and endosomal
protein sorting of cell signaling receptors and other membrane
proteins and inhibit tumor formation by ensuring proper
trafficking and collection of cargoes that function in growth
control, cell survival, and apical-basal polarity in epithelial tissues.
The ESCRT machinery promotes the maturation of early
endosomes into multi-vesicular bodies (MVBs) [10–12]. This is
a complex process that involves four ESCRT complexes, ESCRT-
0, -I, -II and -III. Of interest to this study are the ESCRT-II
components vps22, vps25, and vps36. The products of these genes
mediate the transfer of cargo from ESCRT-I to ESCRT-III [10–
12]. Loss-of-function mutations of these genes block this process,
which causes abnormal signaling and triggers a complex pheno-
type composed of autonomous and non-cell autonomous effects
[5–8].
Previous studies of the mutant phenotypes of ESCRT-II
components and other endocytic nTSGs focused on their mosaic
phenotype, when mutant clones are surrounded by wild-type cells.
Thus, the complex mosaic phenotype of endocytic nTSGs has
been well characterized. Epithelial polarity and proliferation
control are disrupted in mutant clones [1,3,7,9]. Mutant clones
in eye-antennal imaginal discs fail to express the neuronal marker
ELAV, indicating that they fail to differentiate [6,7]. A clear non-
cell autonomous effect of mutant clones on proliferation is
observed in tissues mosaic for tsg101, vps22, or vps25 [3,5,7,8].
The non-mutant tissues surrounding the mutant clones display
increased proliferation [3,5,7]. Such tissues form multilayered
discs and overgrown adult structures [1,3,5–7]. vps25 mutant
clones also promote non-cell autonomous cell survival through
upregulation of the apoptosis inhibitor Diap1 [5,8,13].
In mutant clones of endocytic nTSGs, endosomal trafficking is
blocked and membrane proteins accumulate in abnormal en-
dosomal compartments [1,3,5–9,14]. For example, Notch protein
accumulates in abnormally enlarged early endosomes where it
undergoes ligand-independent processing and activation [1–8].
Active Notch induces non-cell autonomous proliferation in vps22,
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vps25, and tsg101 mosaic tissues through non-cell autonomous
upregulation of JAK/STAT and Yorkie signaling [3,5,7,8,13].
In mosaic tissues, mutant clones of tsg101 and vps25 are
apoptotic [3,5–7]. Apoptosis in these clones is induced by JNK
signaling and the canonical apoptotic pathway (Hid/Diap1/
Dronc/Ark) [5,9,15]. It is commonly believed that JNK signaling
and thus apoptosis is induced by cell competition from neighbor-
ing non-mutant tissue [6,16]. Inhibition of apoptosis in vps25
mutant clones unleashes a strong neoplastic phenotype character-
ized by massive tumorous overgrowth, loss of cell polarity, and
invasive properties [5,6]. Thus, apoptosis serves as a tumor
suppressor mechanism. A strong neoplastic phenotype is also
observed when the entire tissue is mutant for nTSGs, thus when
competitive interactions between mutant and non-mutant tissues
are eliminated [8,17].
From these studies, it is clear that the interactions between the
mutant and non-mutant populations of cells greatly influence the
final phenotype. However, while the non-cell autonomous
mechanisms that cause hyperplastic overgrowth are well charac-
terized, the mechanisms that cause autonomous neoplastic trans-
formation of tissue mutant for endocytic nTSGs are poorly
understood. Because endocytic trafficking controls multiple
signaling pathways, it is likely that tumors caused by mutations
in endocytic nTSGs acquire their neoplastic characteristics
through the de-regulation of numerous signaling pathways. In
hypomorphic tsg101 and vps25 mutant clones, Yorkie signaling is
up-regulated [5,13,15]. However, in strong (null) vps25 mosaic
discs, Yorkie signaling is only detectable non-cell autonomously in
non-mutant neighboring cells [13], suggesting that Yorkie
signaling does not significantly contribute to the neoplastic
phenotype of these mutant clones.
In endocytic nTSG mutant tissues, the protein levels of the
JAK/STAT ligand Unpaired (Upd), the JAK/STAT receptor
Domeless (Dome), and the Drosophila STAT, Stat92E, are in-
creased, leading to increased JAK/STAT signaling activity
[3,6,7,18]. However, the role of JAK/STAT signaling for the
autonomous neoplastic phenotype of nTSG mutant tissue is less
clear. Early evidence has indicated that JAK/STAT signaling may
be involved in this neoplastic transformation; however, that
experiment was done in a heterozygous Stat92E condition
throughout the disc that affects both autonomous and non-cell
autonomous phenotypes [18]. A rigorous assessment of the
neoplastic phenotype in predominantly nTSG mutant tissue in
which JAK/STAT signaling is disrupted has not been performed
yet.
Here, in order to understand the cause of the neoplastic
transformation of these mutant clones, we employed the ey-FLP/
cell lethal (cl) system [19] to generate predominantly mutant tissues
of the ESCRT-II components vps22, vps25 and vps36. These
overgrown, neoplastic tumors display disorganized cellular archi-
tecture and disrupted epithelial structures with expanded apical-
basal domains. Additionally, these tissues are unable to terminally
differentiate and are invasive. Unexpectedly, although competitive
cellular interactions have been largely eliminated by the ey-FLP/cl
method, these predominantly mutant tissues are also very
apoptotic. Within mutant tissues, JNK, Notch, and JAK/STAT
signaling are up-regulated. Reducing JNK activity in ESCRT-II
mutant tissue partially blocks the overproliferation phenotype and
apoptosis but does not otherwise affect neoplastic transformation.
In addition, complete loss of JAK/STAT signaling strongly
rescues the neoplastic phenotype. Thus, this study supports the
idea that de-regulation of signaling pathways, especially JNK and
JAK/STAT signaling, in vps22, vps25, and vps36 mutant tissues
leads to neoplasia.
Materials and Methods
Drosophila Genetics and Generation of Predominantly
Mutant Imaginal Discs
The following mutants and transgenic lines were used: vps225F3-
8 [20], vps25N55 [5], vps36D69(this study), arkH16 [21], Stat92E397
[22], puc-lacZ [23], Gbe-Su(H)-lacZ [24], E(spl)m8 2.61-lacZ [25],
10X-STAT-GFP [26], UAS-bskDN [27], and ey-Gal4 [28]. vps36D69 is
a null allele generated by imprecise excision of the P-element
transposon inserted in the first exon 29 base pairs upstream of the
initiator ATG in the vps36L5212 allele.
To generate imaginal discs predominantly mutant for vps22,
vps25, or vps36, we used the ey-FLP/cl technique [19,28]. cl
indicates an anonymous cell lethal mutation that kills cells when
homozygous [19,28]. The ESCRT-II mutant alleles were crossed
to ey-FLP; FRT cl flies. The use of the FRT depended on the
location of the ESCRT-II gene in the genome. The complete
genotypes are indicated in the legends to the figures.
Immunohistochemistry
Imaginal discs were dissected from third instar larvae and
stained using standard protocols. The following antibodies were
used: mouse a-Dlg (1:20), rat a-ELAV (1:40), mouse a-Mmp1
(catalytic domain; 1:50), and mouse a-Notchintra (1:20; DSHB,
University of Iowa); mouse a-BrdU (1:50; Becton Dickinson);
rabbit a-cleaved Caspase-3 (Cas-3*; 1:500; Cell Signaling Tech-
nology); mouse a-b-gal (1:1,000) and rabbit a-pJNK (1:100;
Promega); and rabbit a-aPKC (1:100; Santa Cruz Biotechnology).
AF488-phalloidin and AF546-phalloidin were obtained from
Sigma Aldrich. Cy-3 and Cy-5 fluorescently-conjugated secondary
antibodies were obtained from Jackson ImmunoResearch. Vecta-
shield with DAPI was obtained from Vector Laboratories.
TUNEL kit was obtained from Roche Diagnostics. Images were
captured using Olympus Optical FV500 or FV1000 confocal
microscopes and processed using Adobe Photoshop CS4.
Results
ESCRT-II Mutant Tissues Show Neoplastic Characteristics
The ey-FLP/cl method generates eye-antennal imaginal discs
that are almost entirely composed of mutant tissue in otherwise
heterozygous animals (see Methods) [19,28]. This is accomplished
by elimination of the twin-spots after ey-FLP-induced mitotic
recombination by a cell lethal (cl) mutation that is present on the
homologous chromosome arm. The use of the ey-FLP ensures high
FLP activity such that most cells undergo mitotic recombination
and only a few heterozygous cells remain. Thus, eye-antennal discs
generated by this method are almost entirely mutant for the gene
of interest.
We used the ey-FLP/cl system to generate tissues predominantly
mutant for ESCRT-II components vps22, vps25, or vps36. These
predominantly mutant epithelial tissues have a very striking
phenotype: unlike wild-type single-layered eye-antennal imaginal
discs, they overgrow into multi-layered, dense ‘‘balls’’ of cells
(Figure 1) [7,8,17]. These discs also vary considerably in size.
Some are about the size of wild-type discs or even slightly smaller
while others can be three to five times as large [8,17]. This was
also reported for other endocytic nTSGs [2,17]. To understand
this tumor-like phenotype in more detail, we examined pro-
liferation, cellular architecture, differentiation, and metastatic
potential of eye-antennal discs predominantly mutant for vps22,
vps25, or vps36.
To assay proliferation in the predominantly mutant tissues, we
used Bromodeoxyuridine (BrdU) labeling to mark cells in S-phase.
Cooperation of Signaling Pathways in Tumorigenesis
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Control discs show the normal BrdU pattern in eye-antennal discs
(Figure 1A). Of note is the posterior part of the eye disc in which
cells are post-mitotic and differentiate into photoreceptor neurons,
cone cells, and other cell types. In discs predominantly mutant for
ESCRT-II components, BrdU labeling indicates that proliferation
is occurring at elevated levels throughout the entire disc
(Figure 1B–D). Post-mitotic areas are not visible or are very small.
Thus, proliferation is up-regulated in tissues predominantly
mutant for vps22, vps25, or vps36.
To examine cellular architecture of tissues predominantly
mutant for ESCRT-II components, we first labeled discs with
phalloidin. Phalloidin recognizes cortical actin and thus highlights
cellular architecture and organization throughout tissues. Control
discs stained with phalloidin show a consistent shape characteristic
of Drosophila eye-antennal imaginal discs (Figure 1A,I,M). Discs
predominantly mutant for ESCRT-II components trade this
characteristic shape for a disorganized, expanded, amorphic
structure in which the antennal and eye portions of the disc
cannot be distinguished (Figure 1B–D,J–L,N–P). Next, to specif-
ically examine epithelial polarity, we labeled predominantly
mutant tissues with antibodies recognizing atypical Protein Kinase
C (aPKC) and Discs large (Dlg). In control tissue, aPKC localizes
to the polarized apical membrane domain while Dlg is found at
the basolateral membrane domain (Figure 1E). In the pre-
dominantly mutant tissues, aPKC and Dlg are spread outside of
their respective regions of wild-type localization (Figure 1F–H),
indicating that apical-basal polarity is disrupted. Together, these
data indicate that cellular architecture is disrupted in vps22, vps25,
and vps36 mutant tissues, which is consistent with previous reports
[7,8,17].
It has been shown previously that clones of vps25 mutant cells in
mosaics fail to differentiate [6,7]. Therefore, we were curious to
examine the ability of cells to differentiate if almost the entire eye-
antennal disc is mutant. Photoreceptor neurons are the first cells
that differentiate during eye development. Using ELAV as
a neuronal marker, we labeled eye-antennal discs almost entirely
mutant for ESCRT-II components to assess differentiation. In the
control eye-antennal imaginal disc, cells in the posterior of the disc
differentiate into neurons and thus show high expression of ELAV
(Figure 1I). In contrast, very few cells in the ESCRT-II pre-
dominantly mutant tissues show ELAV expression (Figure 1J–L).
The cells that are positive for ELAV are not localized to a specific
region of the disc but rather are scattered throughout the tissue.
Thus, similar to mutant cells in a mosaic background, cells in
predominantly mutant eye-antennal imaginal discs fail to differ-
entiate. The few cells that do differentiate likely correspond to the
few heterozygous cells that are present in the disc.
Loss of epithelial integrity and apical-basal polarity, increased
proliferation, and loss of differentiation are hallmarks of neoplastic
transformation. It has also been demonstrated that vps25 mutant
cells have invasive behavior [6]. Matrix metalloprotease 1 (Mmp1)
remodels the extracellular matrix and is known to be elevated in
and required for metastasis of Drosophila tumors [29]. Therefore, to
correlate the metastatic potential of the predominantly mutant
vps22, vps25, and vps36 discs with Mmp1 expression, we labeled
these discs with an antibody recognizing Mmp1. In control eye-
Figure 1. Tissues predominantly mutant for ESCRT-II components vps22, vps25, or vps36 show neoplastic characteristics. Shown are
predominantly mutant eye-antennal imaginal discs. Phalloidin (green) is used to mark the overall shape of the tissue. Scale bars represent 50 mm. (A–
D) BrdU (red and grayscale) labelings show that proliferation is increased in discs predominantly mutant for vps22 (B,B’), vps25 (C,C’), or vps36 (D,D’),
as compared to proliferation in control discs (A,A’). (E–H) aPKC (red and grayscale (E’,F’,G’,H’)) and Dlg (green and grayscale (E’’’,F’’’,G’’’,H’’’)) labelings
of discs predominantly mutant for vps22 (F–F’’’), vps25 (G–G’’’), or vps36 (H–H’’’) show that cellular architecture is disrupted, as compared to the
architecture of control discs (E–E’’’). (I–L) ELAV (red and grayscale) labelings of discs predominantly mutant for vps22 (J,J’), vps25 (K,K’), or vps36 (L,L’)
show that very few cells in the mutant discs differentiate normally, as compared to differentiation in control discs (I,I’). (M–P) Mmp1 (red and
grayscale) labelings of discs predominantly mutant for vps22 (N,N’), vps25 (O,O’), or vps36 (P,P’) show that levels of this protein are elevated, as
compared to Mmp1 levels in control discs (M,M’). Genotypes: (A) eyFLP;; FRT82B/FRT82B cl. (E,I,M) eyFLP; FRT42D y+/FRT42D cl. (B,F,J,N) eyFLP;;
FRT82B vps225F3-8/FRT82B cl. (C,G,K,O) eyFLP; FRT42D vps25N55 y+/FRT42D cl. (D,H,L,P) eyFLP;; vps36D69 FRT80B/cl FRT80B.
doi:10.1371/journal.pone.0056021.g001
Cooperation of Signaling Pathways in Tumorigenesis
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antennal imaginal discs, Mmp1 is present at very low levels
(Figure 1M). In contrast, in the predominantly mutant discs,
Mmp1 is present at high levels throughout the discs (Figure 1N–P).
Taken together, these data demonstrate that ESCRT-II compo-
nents vps22, vps25, and vps36 are strong nTSGs and that eye-
antennal imaginal discs predominantly mutant for these genes
display neoplastic characteristics.
Notch, JAK/STAT, and JNK Signaling are Up-regulated in
ESCRT-II Mutant Tissues
Due to the endosomal sorting defect in ESCRT-II mutant
tissues, multiple signaling pathways are de-regulated [4–8,14,15].
In discs mosaic for ESCRT-II mutants, it is well understood how
de-regulation of signaling contributes to the non-cell autonomous
proliferation and survival phenotypes (see Introduction). However,
these studies in mosaic tissues fail to answer two important
questions: (1) What signaling pathways are de-regulated in
predominantly mutant tissues completely independent from
interactions with non-mutant populations of cells? (2) Does this
autonomous de-regulation of signaling contribute to the autono-
mous neoplastic phenotype? To answer the first question, we
examined levels of Notch, JAK/STAT, and JNK signaling in discs
predominantly mutant for ESCRT-II components.
Multiple studies have shown that Notch signaling is up-
regulated in tissues mosaic for ESCRT components [3–5,7,8,14].
Thus, we were interested to examine levels of the Notch signaling
pathway in tissues predominantly mutant for ESCRT-II compo-
nents. To assess Notch signaling, we used two Notch reporters, the
Gbe-Su(H)-lacZ reporter [24] and the E(spl)m8 2.61-lacZ reporter
[25]. In control discs, Notch signaling is high in a very
stereotypical pattern in the posterior of the eye disc and in the
antennal disc (Figure 2A,B). Use of the Gbe-Su(H)-lacZ reporter in
vps25 mutant discs showed that Notch signaling is very high
throughout the entire disc (Figure 2D). We used the E(spl)-lacZ
reporter to examine Notch activity in vps22 and vps36 mutant
tissues and found that Notch signaling is indeed very high but only
in about half of each mutant disc (Figure 2C,E). To further
examine Notch signaling within mutant discs, we assayed levels of
the Notch protein using an antibody that recognizes the
intracellular portion of the receptor. We found that protein levels
are indeed very high throughout mutant discs (Figure S1B-D),
supporting the results found with the Gbe-Su(H)-lacZ reporter.
From these data, we clearly see that Notch signaling is up-
regulated in tissues predominantly mutant for ESCRT-II compo-
nents.
In genetic mosaics, increased JAK/STAT signaling has been
observed in tsg101 and vps25 mutant clones, and Notch-induced
upregulation of the JAK/STAT ligand Upd has been shown to
contribute to the non-cell autonomous increase of proliferation in
neighboring non-mutant cells [3,5,7,8,18]. Thus, we were in-
terested to see if JAK/STAT signaling is affected autonomously in
predominantly ESCRT-II mutant tissues. To assess levels of JAK/
STAT signaling, we used the well-characterized 10X-STAT-GFP
reporter [26]. In control discs, JAK/STAT signaling is only active
in the posterior portion of the eye disc and in the antennal disc
(Figure 2F). In contrast, JAK/STAT signaling is clearly very
elevated throughout ESCRT-II mutant discs (Figure 2G–I).
One additional pathway that is autonomously induced in
mutant clones of endocytic nTSG mosaics is JNK signaling
[5,9,15,16,30]. It is assumed that JNK signaling is induced by cell
competition between mutant (loser) and non-mutant (winner) cells
in the mosaics. In discs predominantly mutant for ESCRT-II genes,
the competitive interaction between mutant and non-mutant tissue
is removed because most of the non-mutant tissue is eliminated
and only mutant tissue remains. We were therefore surprised to
see strong labeling with the pJNK antibody, which detects
phosphorylated and thus activated JNK, in discs predominantly
mutant for ESCRT-II components compared to controls
(Figure 2J–M). We also observed a strong induction of puc-lacZ,
a JNK-reporter transgene, in discs predominantly mutant for vps25
(Figure S2B). Therefore, JNK activity is induced in ESCRT-II
mutant discs independently of cell competition. Taken together,
these data show that the Notch, JAK/STAT, and JNK signaling
pathways are up-regulated in predominantly ESCRT-II mutant
tissues and support a possible role for these conserved signaling
pathways in the neoplastic phenotype observed in these tissues.
Tissues Predominantly Mutant for ESCRT-II Components
are Apoptotic
JNK signaling in nTSG mutant clones in mosaic discs triggers
apoptosis [5,16,30,31]. Thus, although competitive interactions
are largely abolished in predominantly ESCRT-II mutant discs,
which are often overgrown, we examined these discs for apoptosis.
We assayed cell death by cleaved Caspase-3 (Cas-3*) and TUNEL
labeling in predominantly mutant discs. In control discs, a few
Cas-3* positive cells are scattered throughout the tissue, but most
cells are not apoptotic (Figure 3A). However, surprisingly, discs
predominantly mutant for ESCRT-II genes show high levels of
Cas-3* throughout (Figure 3B–D). Similar results were obtained
with TUNEL labeling (Figure 3E–H), which detects DNA
fragmentation, a hallmark of apoptosis [32], indicating that
apoptosis is indeed occurring. Taken together, although compet-
itive interactions between mutant and non-mutant cells are
eliminated in discs predominantly mutant for ESCRT-II compo-
nents, they display high levels of apoptosis.
So far, we have analyzed the phenotypes of eye-antennal
imaginal discs of ESCRT-II mutants of third instar larvae. We also
observed that animals with eye-antennal imaginal discs pre-
dominantly mutant for ESCRT-II components die as pharate
pupae. Based on our data from imaginal discs, we hypothesized
that the apoptosis of the discs may contribute to the death of the
pharate pupae. Dissection and examination of the pharate pupae
demonstrated that they lack head structures (Figure 4A,B). Thus, it
is likely that the apoptosis of the mutant tissues is leading to the
death of the animal.
Inhibition of JNK Affects the Neoplastic Transformation
of ESCRT-II Mutant Tissues
We were curious to examine the role of apoptosis and JNK
signaling in these discs. JNK is particularly interesting in this
respect because under certain conditions it not only induces
apoptosis, but also non-cell autonomous proliferation [33–35].
Therefore, we blocked apoptosis and JNK signaling in these
mutant tissues and examined the contribution of these pathways to
the neoplastic phenotype of imaginal discs predominantly mutant
for ESCRT-II components.
We first blocked apoptosis in mutant discs by generating discs
that are predominantly double mutant for vps25 and ark, the Apaf-
1 related killer in flies that is an essential component of the cell
death pathway [21,36–40]. In vps25 ark double mutant discs, cell
death is completely inhibited, as shown by Cas-3* labeling
(Figure 5B). In these double mutant discs, the neoplastic
phenotype is even more severe. In some animals, the two eye-
antennal imaginal discs fuse together into one large epithelial mass
(Figure 5F); in a few instances, the two brain lobes and two discs
fuse together into a large mass. These tissue fusions were not
observed in vps25 single mutant discs and may indicate even more
Cooperation of Signaling Pathways in Tumorigenesis
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invasive behavior of apoptosis-inhibited vps25 mutant tissue. High
levels of proliferation, as indicated by BrdU incorporation, are
consistent throughout the entire predominantly mutant tissues
(Figure 5D). Cellular architecture is completely disrupted, as
shown by the drastic spreading of aPKC and Dlg localization
(Figure 5F). A few cells differentiate normally and thus are positive
for ELAV, but most cells fail to differentiate (Figure 5H). Finally,
there are high levels of Mmp1 throughout the mutant tissue,
indicating that the tissue has the potential to be invasive (Figure 5J).
Importantly, eye-antennal imaginal discs predominantly mutant
for ark alone do not show any neoplastic characteristics
(Figure 5C,E,G,I). Therefore, it is clear that cell death is not
required for neoplastic transformation in tissues predominantly
mutant for ESCRT-II components. In contrast, since the
phenotype of vps25 ark double mutant discs is more severe than
that of vps25 single mutant discs (Figure 1), apoptosis in these
mutant discs serves as a tumor suppressor mechanism to eliminate
the cancerous tissue.
We also examined the role of JNK signaling in apoptosis,
proliferation and neoplastic characteristics in discs predominantly
mutant for ESCRT-II genes by inhibiting JNK signaling through
overexpression of a dominant negative form of the Drosophila JNK
homologue basket (bsk), bskDN [27], using ey-Gal4. In control discs,
overexpression of bskDN in otherwise wild-type discs has no
apparent effect on architecture, polarity, differentiation, and
Mmp1 expression (Figure 5K,M, Figure S3A,C,E). However,
compared to the apoptosis observed in vps25 mutant discs
(Figure 3C,G), TUNEL-positive cell death is strongly suppressed
by expression of bskDN in discs predominantly mutant for vps25
(Figure 5L) suggesting that JNK signaling contributes to the
apoptotic phenotype of predominantly mutant ESCRT-II eye discs.
Intriguingly, the proliferation pattern is also reduced in these discs,
Figure 2. Notch, JAK/STAT, and JNK signaling are upregulated in vps22, vps25, and vps36 mutant tissues. Shown are predominantly
mutant eye-antennal imaginal discs. Phalloidin (green) is used to mark the overall shape of the tissue. Gbe-Su(H)-lacZ, and E(spl)m8 2.61-lacZ are
detected by b-gal labeling (red or grayscale). Scale bars represent 50 mm. (A,E) Imaginal discs predominantly mutant for vps25 induce high levels of
Gbe-Su(H)-lacZ (E), as compared to control discs (A,A’). (B,C,E) Imaginal discs predominantly mutant for vps22 (C) or vps36 (E) induce high levels of
E(spl)m8 2.61-lacZ, as compared to control discs (B,B’). (F–I) Imaginal discs predominantly mutant for vps22 (G), vps25 (H), or vps36 (I) induce high
levels of 10X-STAT-GFP, as compared to control discs (F,F’). (J–M) Imaginal discs predominantly mutant for vps22 (K), vps25 (L), or vps36 (M) show high
levels of phosphorylated JNK protein, as compared to control discs (J,J’). Genotypes: (A) eyFLP; FRT42D y+/FRT42D cl; Gbe-Su(H)-lacZ/+. (B) eyFLP;
E(Spl)m8 2.61-lacZ/+; FRT82B/FRT82B cl. (C) eyFLP; E(spl)m8 2.61-lacZ/+; FRT82B vps225F3-8/FRT82B cl. (D) eyFLP; FRT42D vps25N55 y+/FRT42D cl; Gbe-
Su(H)-lacZ/+. (E) eyFLP; E(spl)m8 2.61-lacZ/+; vps36D69 FRT80B/cl FRT80B. (F) eyFLP; FRT42D y+/FRT42D cl; 10X-STAT-GFP/+. (G) eyFLP; 10X-STAT-GFP/+;
FRT82B vps225F3-8/FRT82B cl. (H) eyFLP; FRT42D vps25N55 y+/FRT42D cl; 10X-STAT-GFP/+. (I) eyFLP; 10X-STAT-GFP/+; vps36D69 FRT80B/cl FRT80B. (J) eyFLP;
FRT42D y+/FRT42D cl. (K) eyFLP;; FRT82B vps225F3-8/FRT82B cl. (L) eyFLP; FRT42D vps25N55 y+/FRT42D cl. (M) eyFLP;; vps36D69 FRT80B/cl FRT80B.
doi:10.1371/journal.pone.0056021.g002
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as assayed by BrdU labeling (Figure 5N), implying that JNK-
induced proliferation at least partially contributes to the strong
proliferation phenotype of vps25 mutant discs. Labeling with
phalloidin (Figure 5N, Figure S3D,F) and staining with antibodies
recognizing aPKC and Dlg (Figure S3B) both indicate that cellular
architecture remains disrupted even when JNK signaling is
inhibited. Mutant discs have lost their characteristic shape and
instead are simply dense ‘‘balls’’ of cells. aPKC and Dlg are both
spread outside of their normal domains of localization. Only a few
cells in the disc are positive for the differentiation marker ELAV,
and they are spread throughout the disc (Figure S3D). Finally,
despite a report that JNK can induce Mmp1 expression [35],
expression of bskDN in discs predominantly mutant for vps25 does
not suppress the elevated levels of Mmp1 expression (Figure S3F),
suggesting that other mechanisms can also induce Mmp1. Thus,
while inhibition of JNK signaling partially blocks apoptosis and
proliferation, is has no effect on the other neoplastic characteristics
seen in ESCRT-II mutant cells.
Inhibition of JAK/STAT Signaling Significantly Rescues
the Neoplastic Transformation of ESCRT-II Mutant Tissues
Since we saw increased levels of JAK/STAT signaling in
ESCRT-II mutant tissues, we investigated the possible autono-
Figure 3. Imaginal discs predominantly mutant for vps22, vps25, or vps36 are apoptotic. Shown are predominantly mutant eye-antennal
imaginal discs. Phalloidin (green) or DAPI (green) is used to mark the overall shape of the tissue. Scale bars represent 50 mm. (A–D) Cleaved Caspase-3
(Cas-3*; red and grayscale) labelings show that apoptosis is increased in discs predominantly mutant for vps22 (B), vps25 (C), or vps36 (D), as
compared to apoptosis in control discs (A,A’). (E–H) TUNEL (red and grayscale) labelings show that apoptosis is increased in discs predominantly
mutant for vps22 (F), vps25 (G), or vps36 (H), as compared to apoptosis in control discs (E,E’). Genotypes: (A) eyFLP; FRT42D y+/FRT42D cl. (B,F) eyFLP;;
FRT82B vps225F3-8/FRT82B cl. (C,G) eyFLP; FRT42D vps25N55/FRT42D cl. (D,H) eyFLP;; vps36D69 FRT80B/cl FRT80B. (E) eyFLP;; FRT82B/FRT82B cl.
doi:10.1371/journal.pone.0056021.g003
Figure 4. Animals with imaginal discs predominantly mutant for ESCRT-II components die as headless pharate pupae. Animals with
predominantly mutant tissues are generated with the eyFLP-cl system. (A,B) Animals with eye-antennal imaginal discs predominantly mutant for
vps22 (A) or vps25 (B) die as pharate pupae that lack heads. Genotypes: (A) eyFLP;; FRT82B vps225F3-8/FRT82B cl. (B) eyFLP; FRT42D vps25N55 y+/FRT42D
cl.
doi:10.1371/journal.pone.0056021.g004
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mous role of JAK/STAT signaling in predominantly mutant
tissues. A previous study examined tsg101 mutant discs in
a heterozygous Stat92E mutant background and reported
a genetic interaction [18], but due to the heterozygous Stat92E
condition, a rigorous analysis of the role of JAK/STAT
signaling in the neoplastic transformation of nTSG mutant
tissue has not been completed. To accomplish this, we
completely inhibited JAK/STAT signaling in vps22 mutant
tissues using the null allele Stat92E397. We used vps22 in these
experiments because vps22 and Stat92E both map to the same
chromosome arm (3R), allowing a convenient double mutant
analysis. It was recently shown that Stat92E mutant clones are
eliminated by cell competition [41]. Interestingly, control discs
predominantly mutant for Stat92E in which competitive
interactions are eliminated reveal only weak abnormalities
(Figure 6A,C,E,G). The proliferation pattern appears slightly
abnormal (Figure 6A), and discs of slightly reduced size are
generated. Importantly, overall tissue architecture
(Figure 6A,E,G), apical-basal polarity (Figure 6C), and differen-
tiation (Figure 6E) are normal in predominantly mutant Stat92E
discs. There is also no Mmp1 expression in these discs
(Figure 6G).
However, loss of JAK/STAT signaling in vps22 mutant discs
(vps22 Stat92E double mutants) strongly rescues the neoplastic
characteristics seen in vps22 single mutant tissues. The disorgani-
zation of cellular architecture observed in vps22 mutant discs is
significantly rescued by removal of JAK/STAT signaling.
Labeling with phalloidin shows that double mutant discs retain
their characteristic eye-antennal imaginal disc shape
(Figure 6B,F,H). Staining with antibodies recognizing aPKC and
Dlg reveals that spreading of these two proteins outside their wild-
type domains of localization is minimized with most aPKC
localized to the apical membrane domain and most Dlg localized
to the basolateral membrane domain (Figure 6D). Thus, removal
of JAK/STAT signaling leads to rescue of the disorganization of
cellular architecture observed in vps22 mutant tissues.
Loss of JAK/STAT signaling in discs predominantly mutant for
vps22 also significantly rescues the failure of differentiation seen in
vps22 mutant discs (Figure 6F). Few cells are positive for ELAV in
vps22 mutant discs, and cells that are differentiating normally are
scattered throughout the tissue (Figure 1J–L). In striking contrast,
when JAK/STAT signaling is inhibited, the entire posterior
domain of the disc is positive for ELAV (Figure 6F), indicating that
many cells are undergoing normal differentiation. This ELAV
pattern is hardly distinguishable from the wild-type pattern
(Figure 1I), implying that hyperactive JAK/STAT signaling in
vps22 mutant cells inhibits differentiation.
Loss of JAK/STAT signaling in vps22 mutant discs, however,
has little to no effect on Mmp1 expression. Mmp1 levels remain
elevated throughout the tissue (Figure 6H), suggesting that
JAK/STAT signaling is not required for Mmp1 expression and
for possible metastatic capability. Thus, elevated JAK/STAT
signaling in ESCRT-II mutant tissue plays a very important role
in the neoplastic transformation, leading to both disorganization
of cellular architecture and failure of differentiation.
Discussion
While it is well established how de-regulated signaling pathways
in ESCRT-II mutant clones mediate non-cell autonomous inter-
actions with neighboring non-mutant cells to contribute to
hyperplastic overgrowth and increased cell survival [1,3,5–9,13],
it was largely unknown which signaling pathways trigger neoplastic
transformation autonomously. To address this question, we
generated predominantly mutant eye-antennal imaginal discs in
which competitive interactions are eliminated so that we could
examine the autonomous results of de-regulated signaling.
Overall, it appears that the same signaling pathways that are
induced in mosaic clones are also activated in predominantly
mutant tissues. However, two results of this study are noteworthy.
First, it is surprising that JNK activity is strongly induced in tissues
predominantly mutant for ESCRT-II genes. This is surprising
because JNK signaling was believed to be induced by cell
competition from neighboring non-mutant cells in mosaic tissues
[6,16,30]. However, non-mutant tissue is largely eliminated by the
ey-FLP/cl method and thus competitive interactions are eliminat-
ed. Therefore, it is not known how JNK signaling is induced in
these tissues. Nevertheless, JNK signaling is critical for the
overgrowth phenotype of predominantly ESCRT-II mutant eye
discs as inhibition of this pathway partially blocks cell proliferation.
Second, de-regulation of the JAK/STAT signaling pathway is
critical for the neoplastic transformation of vps22 mutant discs.
Loss of JAK/STAT signaling dramatically normalizes the neo-
plastic phenotype of vps22 mutant cells. In addition to JNK and
JAK/STAT activity, we also found Notch activity increased in
discs predominantly mutant for ESCRT-II genes. Therefore, we
tested a genetic requirement of Notch signaling for neoplastic
transformation of ESCRT-II mutant cells. However, loss of Notch
was inconclusive because even the wild-type control discs did not
grow when Notch was inhibited (data not shown).
Interestingly, although ESCRT-II mutant tissues undergo
neoplastic transformation, they also show high levels of
apoptosis. Animals with predominantly mutant eye-antennal
imaginal discs die as headless pharate pupae, a phenotype likely
Figure 5. Inhibition of apoptosis affects the neoplastic transformation of ESCRT-II mutant tissue. Shown are predominantly mutant eye-
antennal imaginal discs. Phalloidin (green) or DAPI (green) is used to mark the overall shape of the tissue. Scale bars represent 50 mm. (A–J)
Apoptosis is inhibited by removal of ark. (A,B) Cleaved Caspase-3 (Cas-3*; red and grayscale) labelings show that apoptosis is completely inhibited in
discs predominantly mutant for vps25 and ark (B,B’). Cell death is also absent in discs predominantly mutant for ark (A,A’). (C,D) BrdU (red and
grayscale) labelings show that proliferation is elevated in tissues predominantly mutant for vps25 and ark (D,D’). Proliferation is not affected in control
tissues predominantly mutant for ark (C,C’). (E,F) aPKC (red and grayscale (E’,F’)) and Dlg (green and grayscale (E’’’,F’’’)) labelings of discs
predominantly mutant for vps25 and ark show that cellular architecture is disrupted (F–F’’’). Cellular architecture is not disrupted in control discs
predominantly mutant for ark (E–E’’’). (G,H) ELAV (red and grayscale) labelings of discs predominantly mutant for vps25 and ark show that very few
cells in the double mutant discs differentiate normally (H,H’). Differentiation occurs normally in control discs predominantly mutant for ark (G,G’). (I,J)
Mmp1 (red and grayscale) labelings of discs predominantly mutant for vps25 and ark show that levels of this protein are increased (J,J’). Mmp1 levels
are not affected in control discs predominantly mutant for ark (I,I’). (K–N) Apoptosis is reduced by inhibition of JNK signaling by expression of the
UAS-bskDN transgene using ey-Gal4. Phalloidin (green) or DAPI (green) is used to mark the overall shape of the tissue. (K,L) TUNEL (red and grayscale)
labelings show that apoptosis is reduced in discs predominantly mutant for vps25 in which JNK signaling is inhibited (L,L’). Apoptosis is also low in
control discs in which JNK signaling is inhibited (K,K’). (M,N) BrdU (red and grayscale) labelings show that proliferation is reduced in tissues
predominantly mutant for vps25 in which JNK signaling is inhibited (N,N’). Proliferation is not affected in control discs in which JNK signaling is
inhibited (M,M’). Genotypes: (A,C,E,G,I) eyFLP; FRT42D arkH16/FRT42D cl. (B,D,F,H,J) eyFLP; FRT42D vps25N55 arkH16/FRT42D cl. (K,M) eyFLP/UAS-
bskDN; FRT42D y+/FRT42D cl; ey-Gal4/+. (L,N) eyFLP/UAS-bskDN; FRT42D vps25N55 y+/FRT42D cl; ey-Gal4/+.
doi:10.1371/journal.pone.0056021.g005
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caused by the apoptosis of the imaginal discs before the adult
stage. Reduction of JNK signaling in vps22, vps25, or vps36
mutant discs leads to lower levels of apoptosis, supporting a role
for JNK signaling in the cell death of the predominantly mutant
tissues. More excitingly, JNK also controls proliferation in these
tissues, as shown by the reduction of proliferation seen when
JNK signaling was down-regulated. This observation is consis-
tent with previous findings that JNK can induce non-cell
autonomous proliferation [35] and that apoptosis-induced
proliferation is mediated by JNK activity [33,34,42]. While
inhibition of JNK signaling reduces proliferation in predomi-
nantly mutant ESCRT-II mutant discs, it does not affect other
aspects of the neoplastic phenotype.
The role of JAK/STAT signaling in these mutants is complex.
In mutant clones of ESCRT-II mosaic discs, Notch-induced
secretion of the JAK/STAT ligand Upd triggers non-cell
Figure 6. Inhibition of JAK/STAT signaling partially rescues the neoplastic transformation of ESCRT-II mutant tissue. Shown are
predominantly mutant eye-antennal imaginal discs. Phalloidin (green) is used to mark the overall shape of the tissue. Scale bars represent 50 mm.
(A,B) BrdU (red and grayscale) labelings show that proliferation is elevated in tissues predominantly mutant for vps22 and Stat92E (B,B’) Proliferation
is slightly abnormal in control tissues predominantly mutant for Stat92E (A,A’). (C,D) aPKC (red and grayscale (C’,D’)) and Dlg (green and grayscale
(C’’’,D’’’)) labelings of discs predominantly mutant for vps22 and Stat92E show that cellular architecture is largely intact (D–D’’’). Cellular architecture is
not disrupted in control discs predominantly mutant for Stat92E (C–C’’’). (E,F) ELAV (red and grayscale) labelings of discs predominantly mutant for
vps22 and Stat92E show that differentiation is completely rescued (F,F’) from the loss of differentiation seen in ESCRT-II mutant discs. Differentiation
occurs normally in control discs predominantly mutant for Stat92E (E,E’). (G,H) Mmp1 (red and grayscale) labelings of discs predominantly mutant for
vps22 and Stat92E show that levels of this protein are increased (H,H’). Mmp1 levels are not affected in control discs predominantly mutant for Stat92E
(G,G’). Genotypes: (A,C,E,G) eyFLP;; FRT82B Stat92E397/FRT82B cl. (B,D,F,H) eyFLP;; FRT82B vps225F3-8 Stat92E397/FRT82B cl.
doi:10.1371/journal.pone.0056021.g006
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autonomous proliferation [5,7]. However, we observed that
autonomous de-regulated JAK/STAT signaling in predominately
mutant discs is critical for the neoplastic transformation of vps22
mutants. In vps22 Stat92E double mutant discs, organization of
cellular architecture is definitively rescued with the layout of the
tissue closely resembling that of a wild-type eye-antennal imaginal
disc. In addition, apical-basal polarity markers are localized more-
or-less correctly in these tissues, indicating that epithelial polarity is
more intact. Finally, differentiation in the posterior portion of the
eye disc is preserved when JAK/STAT signaling is inhibited.
Thus, de-regulation of JAK/STAT signaling in vps22 mutant discs
contributes to the cellular disorganization and the lack of
differentiation seen in the tissues, which is consistent with
a previous study that implicated JAK/STAT signaling in cell
cycle control, cell size, and epithelial organization in tsg101 mutant
tissues [18].
It was recently shown that cells with strong gain of JAK/STAT
activity transform into supercompetitors and eliminate neighbor-
ing cells with normal JAK/STAT activity by cell competition [41].
However, in mosaic discs, a supercompetitive behavior of ESCRT-
II mutant cells has not been observed. In fact, these mutant cells
are eliminated by apoptosis. Only if apoptosis is blocked in these
cells, is a strong overgrowth phenotype with neoplastic character-
istics observed [5,6]. Thus, apoptosis can serve as a tumor
suppressor mechanism to remove cells with potentially malignant
JAK/STAT activity.
How endosomal trafficking specifically regulates JAK/STAT
signaling and, thus, how blocking trafficking leads to increases in
signaling pathway activity are interesting questions to answer in
the future. It is possible that, like endocytic regulation of the Notch
receptor, the endosomal pathway tightly regulates Domeless
(Dome), the JAK/STAT pathway receptor. It has been shown
previously that Dome is trafficked through the endocytic
machinery and that this trafficking of Dome can affect the
downstream output of the JAK/STAT signaling pathway [43,44].
It is also possible that Notch-induced Upd secretion causes
autocrine JAK/STAT signaling in these mutants. However,
technical problems (knocking down Notch function both in wild-
type and mutant tissue causes general problems in tissue growth)
prevented us from examining this possibility.
It will be important to examine how de-regulated JAK/STAT
signaling in ESCRT-II mutants causes neoplastic transformation.
JAK/STAT signaling is known to be an oncogenic pathway in
Drosophila [45–49] and in humans [50] but its downstream targets
that promote tumorigenesis are not yet clear. JAK/STAT
signaling may be feeding into other pathways that promote
tumorigenesis, such as dpp signaling [45], or may be targeting
other proteins involved in transformation, such as Cyclin D
[46,51–54].
A number of studies have implicated genes that function in
endocytosis and endosomal protein sorting as tumor suppressors
in human cancers. Most well known is Tsg101, as early studies
showed that downregulation of Tsg101 promotes the growth of
mouse 3T3 fibroblasts in soft agar [55]. When these cells were
injected into nude mice, they formed metastatic tumors [55].
However, later studies have shown conflicting results [56–58],
and it is still unclear if Tsg101 functions as a tumor suppressor
in metazoans. Importantly, a number of studies have shown
changes in expression of ESCRT components in human cancer
cells, including changes in expression of ESCRT-I components
Tsg101 [59–62] and Vps37A [63,64] and ESCRT-III compo-
nents Chmp1A and CHMP3 [63,65]. Since the primary
proteins that function in endocytosis and endosomal trafficking
are conserved from yeast to humans, it is likely that our findings
in Drosophila may have important implications for human
disease.
Supporting Information
Figure S1 Notch protein levels are upregulated in
vps22, vps25, and vps36 mutant tissues. Shown are
predominantly mutant eye-antennal imaginal discs. Scale bars
represent 50 mm. Phalloidin (green) is used to mark the overall
shape of the tissue. Notch protein levels (red, grayscale) are shown
by staining with an antibody recognizing the intracellular domain
of the protein (a-Nintra). Notch protein levels are increased in
imaginal discs predominantly mutant for vps22 (B), vps25 (C), or
vps36 (D), as compared to Notch protein levels in control discs
(A,A’). Genotypes: (A) eyFLP;; FRT82B/FRT82B cl. (B) eyFLP;;
FRT82B vps225F3-8/FRT82B cl. (C) eyFLP; FRT42D vps25N55 y+/
FRT42D cl. (D) eyFLP;; vps36D69 FRT80B/cl FRT80B.
(TIF)
Figure S2 JNK signaling is upregulated in tissues pre-
dominantly mutant for vps25. Shown are predominantly
mutant eye-antennal imaginal discs. Phalloidin (green) is used to
mark the overall shape of the tissue. puc-lacZ is detected by b-gal
labeling (red or grayscale). (A-B) Imaginal discs predominantly
mutant for vps25 induce high levels of puc-lacZ (B), as compared to
puc-lacZ expression in control discs (A,A’). Scale bars represent
50 mm. Genotypes: (A) eyFLP; FRT42D/FRT42D cl; puc-LacZ/+.
(B) eyFLP; FRT42D vps25N55 y+/FRT42D cl; puc-LacZ/+.
(TIF)
Figure S3 Inhibition of JNK signaling does not affect the
disorganization of cellular architecture, the failure of
differentiation, and the invasive potential of ESCRT-II
mutant tissue. Shown are predominantly mutant eye-antennal
imaginal discs. JNK signaling is inhibited by expression of the
UAS-bskDN transgene using ey-Gal4. Phalloidin (green) is used to
mark the overall shape of the tissue. Scale bars represent 50 mm.
(A,B) aPKC (red and grayscale (A’,B’)) and Dlg (green and
grayscale (A’’’,B’’’)) labelings of discs predominantly mutant for
vps25 in which JNK signaling is inhibited show that cellular
architecture is disrupted (B-B’’’). Cellular architecture is not
disrupted in control discs in which JNK signaling is inhibited (A-
A’’’). (C,D) ELAV (red and grayscale) labelings of discs pre-
dominantly mutant for vps25 in which JNK signaling is inhibited
show that very few cells in the mutant discs differentiate normally
(D,D’). Differentiation occurs normally in control discs in which
JNK signaling is inhibited (C,C’). (E,F) Mmp1 (red and grayscale)
labelings of discs predominantly mutant for vps25 in which JNK
signaling is inhibited show that levels of this protein are increased
(F,F’). Mmp1 levels are not affected in control discs in which JNK
signaling is inhibited (E,E’). Genotypes: (A,C,E) eyFLP/UAS-bskDN;
FRT42D y+/FRT42D cl; ey-Gal4/+. (B,D,F) eyFLP/UAS-bskDN;
FRT42D vps25N55 y+/FRT42D cl; ey-Gal4/+.
(TIF)
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